API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.pierre-fabre.com/en/press_release/kinnate-biopharma-inc-sells-its-investigational-pan-raf-inhibitor-exarafenib-to
https://www.globenewswire.com//news-release/2024/03/01/2838802/0/en/Kinnate-Biopharma-Inc-Sells-Its-Investigational-Pan-RAF-Inhibitor-Exarafenib-to-Pierre-Fabre-Laboratories.html
https://www.globenewswire.com/news-release/2023/04/17/2648391/0/en/First-Report-of-Positive-Dose-Escalation-Data-Supports-Best-in-Class-Profile-for-Investigational-Exarafenib-as-a-Single-Agent-and-in-Combination-with-Binimetinib-in-BRAF-altered-Ca.html